YBX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.868400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.415360E-01
Normal-vs-Stage2
7.723200E-01
Normal-vs-Stage3
5.266000E-01
Normal-vs-Stage4
9.501200E-01
Stage1-vs-Stage2
2.833400E-01
Stage1-vs-Stage3
6.955000E-01
Stage1-vs-Stage4
1.377590E-01
Stage2-vs-Stage3
6.374600E-01
Stage2-vs-Stage4
7.050000E-01
Stage3-vs-Stage4
4.847600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.128800E-01
Normal-vs-AfricanAmerican
6.591000E-01
Normal-vs-Asian
1.342850E-01
Caucasian-vs-AfricanAmerican
8.937600E-01
Caucasian-vs-Asian
1.057790E-01
AfricanAmerican-vs-Asian
2.067600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.214410E-01
Normal-vs-Female
6.953400E-01
Male-vs-Female
7.164800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.994630E-01
Normal-vs-Age(41-60Yrs)
8.252800E-01
Normal-vs-Age(61-80Yrs)
5.745600E-02
Normal-vs-Age(81-100Yrs)
9.116600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.371800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.492400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.031800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.502240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.202200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.475400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.782600E-01
Normal-vs-Daily Drinker
4.679000E-01
Normal-vs-Weekly Drinker
6.511400E-01
Normal-vs-Occasional Drinker
6.399000E-01
Normal-vs-Social Drinker
5.157600E-01
Non Drinker-vs-Daily Drinker
6.770600E-01
Non Drinker-vs-Weekly Drinker
4.920200E-01
Non Drinker-vs-Occasional Drinker
2.272200E-01
Non Drinker-vs-Social Drinker
4.421800E-01
Daily Drinker-vs-Weekly Drinker
6.618800E-01
Daily Drinker-vs-Occasional Drinker
4.276000E-01
Daily Drinker-vs-Social Drinker
7.013600E-01
Weekly Drinker-vs-Occasional Drinker
9.890800E-01
Weekly Drinker-vs-Social Drinker
8.401000E-01
Occasional Drinker-vs-Social Drinker
6.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.226600E-01
Normal-vs-Grade 2
7.609200E-01
Normal-vs-Grade 3
7.457600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.997000E-01
Grade 1-vs-Grade 3
6.866400E-01
Grade 1-vs-Grade 4
7.226600E-01
Grade 2-vs-Grade 3
5.073000E-01
Grade 2-vs-Grade 4
7.609200E-01
Grade 3-vs-Grade 4
7.457600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.896000E-01
Normal-vs-NonDiabetic
4.573600E-01
Diabetic-vs-NonDiabetic
3.759400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.764400E-01
Normal-vs-NoPancreatitis
5.478000E-01
Pancreatitis-vs-NoPancreatitis
7.168800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.085400E-01
Normal-vs-N1
3.026600E-01
N0-vs-N1
1.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.267200E-01
Normal-vs-TP53-NonMutant
1.698450E-02
TP53-Mutant-vs-TP53-NonMutant
9.779900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
